The state of value-based contracting 2.0 - Prime Therapeutics
The state of value-based contracting 2.0
An update on Medicaid payment models and opportunities
Value-based contracts (VBCs) are performance-based reimbursement agreements between health care payers and pharmaceutical manufacturers in which the price, amount or nature of reimbursement is tied to outcomes. With the dawn of multimillion dollar, potentially curative cell and gene therapies, the traditional rebate-per-unit model is no longer a viable solution for Medicaid payers. The strategy brief below provides an update on Medicaid payment models and opportunities.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.